Compositions for the treatment of rheumatoid arthritis and methods of using same
US10927435B2 · kind B2 · utility
5Cited by
36References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2012 |
| Grant date | Feb 23, 2021 |
| Priority date | — |
| Expiry date | Oct 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC22F1/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.